Resources with keywords: Poliovirus
CDC has updated interenational travel recommendations for an increased number of countries to “Level 2 – Practice Enhanced Precautions”. This page will be updated reguarly based on circulating polio cases.
Poliovirus PHEIC ongoing since 2014. WHO and CDC require all laboratory workers handling poliovirus or specimens potentially containing poliovirus to be fully vaccinated with IPV. Following global certification of wild poliovirus type 2 and type 3 eradication, all WPV2 and WPV3 work must occur in poliovirus-essential facilities (PEFs) under WHO Global Action Plan III (GAPIII) containment standards. USDA ARS laboratories should confirm no unauthorized poliovirus materials are retained in freezer inventories.
Between September and December 2024, four countries in the EU/EEA (Finland, Germany, Poland, Spain) and the United Kingdom reported detections of circulating vaccine-derived poliovirus type 2 (cVDPV2) in sewage samples. This is the first time cVDPV2 has been detected in EU/EEA countries from environmental surveillance.
EID Whitehouse ER, Gerloff N, English R, Reckling SK, Alazawi MA, Fuschino M, et al.
Includes map of current distribution. Some international destinations have circulating poliovirus.
Kidd S, Clark T, Routh J, Cineas S, Bahta L, Brooks O
New recommendations include that adults aged ≥18 years who are known or suspected to be unvaccinated or incompletely vaccinated against polio should complete a primary polio vaccination series with IPV.
Horsington J, et.al.
Discusses the application of the Nagoya Protocol to veterinary pathogens (concerns for the control of foot-and-mouth disease).
Bigouette JP, Henderson E, Traoré MA, et al.
